CLEVELAND, Ohio (WOIO) - The Drug Enforcement Administration (DEA) is trying to keep prescription drugs from getting into the wrong hands. We looked into how they’re making sure pharmacies and doctors ...
Reform or dismantle the DEA's Diversion Control Division and transfer oversight of controlled-substance pharmaceuticals to the FDA or NIH, where science-not outdated drug war politics-guides policy.
COLUMBUS, Ohio — The Drug Enforcement Administration is ramping up efforts to prevent prescription drugs from falling into the wrong hands, with a focus on curbing misuse that can begin within the ...
The Compliance Team is hosting a webinar with Elena Jacques, diversion program specialist with the Drug Enforcement Administration, Diversion Control Division, on Thursday, Aug. 14, from 2:00 pm – ...
Unjustified Delays: MMJ International Holdings claims that these officials have been instrumental in the multi-year delays of their application to cultivate pharmaceutical-grade marijuana, necessary ...
DEA Back to Training School, DEA Bureaucrat Blocks Science While Ignoring their Own TRAINING Manual. DEA Assistant Administrators and attorney needs a summer assignment, and MMJ BioPharma Cultivation ...
The DEA Diversion Control Problem: A Hidden Threat to U.S. Pharmaceutical Manufacturing ? Take the case of MMJ BioPharma Cultivation - despite submissions of FDA Investigational New Drug (IND) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results